These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12957447)

  • 1. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
    J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
    Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
    Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
    Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.
    Wolf CM; Arad M; Ahmad F; Sanbe A; Bernstein SA; Toka O; Konno T; Morley G; Robbins J; Seidman JG; Seidman CE; Berul CI
    Circulation; 2008 Jan; 117(2):144-54. PubMed ID: 18158359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
    Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.
    Gollob MH; Green MS; Tang AS; Roberts R
    Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
    J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological Expression of AMPKγ2RG Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice.
    Yang X; Mudgett J; Bou-About G; Champy MF; Jacobs H; Monassier L; Pavlovic G; Sorg T; Herault Y; Petit-Demoulière B; Lu K; Feng W; Wang H; Ma LJ; Askew R; Erion MD; Kelley DE; Myers RW; Li C; Guan HP
    J Biol Chem; 2016 Nov; 291(45):23428-23439. PubMed ID: 27621313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
    Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
    Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
    Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
    Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
    J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Electrophysiologic Profiles in Pediatric Patients with Incidentally Identified Pre-Excitation Compared with Wolff-Parkinson-White Syndrome.
    LaRocca TJ; Beyersdorf GB; Li W; Foltz R; Patel AR; Tanel RE
    Am J Cardiol; 2019 Aug; 124(3):389-395. PubMed ID: 31204032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation.
    Sternick EB; Oliva A; Gerken LM; Magalhães L; Scarpelli R; Correia FS; Rego S; Santana O; Brugada R; Wellens HJ
    Heart Rhythm; 2011 Jan; 8(1):58-64. PubMed ID: 20888928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
    Chen SA; Tai CT; Chiang CE; Lee SH; Wen ZC; Chiou CW; Ueng KC; Chen YJ; Yu WC; Huang JL; Chang MS
    J Am Coll Cardiol; 1996 Sep; 28(3):732-7. PubMed ID: 8772764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial preexcitation and pseudo-preexcitation syndromes.
    Scheinman MM
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):733-4. PubMed ID: 16836668
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
    Ahmad F; Arad M; Musi N; He H; Wolf C; Branco D; Perez-Atayde AR; Stapleton D; Bali D; Xing Y; Tian R; Goodyear LJ; Berul CI; Ingwall JS; Seidman CE; Seidman JG
    Circulation; 2005 Nov; 112(20):3140-8. PubMed ID: 16275868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular dyssynchrony in pre-excitation syndrome: effect of accessory pathway location and reversibility after ablation therapy.
    Park HE; Chang SA; Kim JH; Oh IY; Choi EK; Oh S
    Heart Vessels; 2013 Mar; 28(2):199-207. PubMed ID: 22349776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.